Description
Indication:Peglasp is indicated as a component of multi agent chemotherapeutic regimen for the treatment of patients with Acute Lymphoblastic Leukemia who are sensitive to L asparaginase
Additional information
| Indications: | Peglasp is indicated as a component of multi agent chemotherapeutic regimen for the treatment of patients with Acute Lymphoblastic Leukemia who are sensitive to L asparaginase |
|---|---|
| Abbreviation: | International Unit / Milligram |
| Shelf Life: | 24 Months |
| Storage: | 2ºC to 80ºC |
| How Supplied: | 5ml single use vial |
| Prescription /Nonprescription: | Prescription |
